Matinas BioPharma
MTNB
MTNB
50 hedge funds and large institutions have $12.6M invested in Matinas BioPharma in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
50
Holders Change
-7
Holders Change %
-12.28%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
10
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
BlackRock
New York
|
$1.16M |
| 2 |
VF
2
Virtu Financial
New York
|
$0 |
| 3 |
3
Jane Street
New York
|
$27.2K |
| 4 |
SIG
4
Sargent Investment Group
Bethesda,
Maryland
|
$2.08M |
| 5 |
BCM
5
Bridgeway Capital Management
Houston,
Texas
|
$260K |
